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Abstract
The protective antigen (PA) component of the anthrax toxin forms pores within the low pH
environment of host endosomes, through mechanisms that are poorly understood. It has been
proposed that pore formation is dependent on histidine protonation. In previous work, we
biosynthetically incorporated 2-fluorohistidine (2-FHis), an isosteric analog of histidine with a
significantly reduced pKa (~1), into PA, and showed that the pH-dependent conversion from the
soluble prepore to a pore was unchanged. However, we also observed that 2-FHisPA was non-
functional in the ability to mediate cytotoxicity of CHO-K1 cells by LFN-DTA, and was defective
in translocation through planar lipid bilayers. Here, we show that the defect in cytotoxicity is due
to both a defect in translocation and, when bound to the host cellular receptor, an inability to
undergo low pH-induced pore formation. Combining X-ray crystallography with hydrogen-
deuterium (H-D) exchange mass spectrometry, our studies lead to a model in which hydrogen
bonds to the histidine ring are strengthened by receptor binding. The combination of both
fluorination and receptor binding is sufficient to block low pH-induced pore formation.
Anthrax toxin is an AB toxin secreted by Bacillus anthracis and is required for disease
pathogenesis (1). The B component, the protective antigen (PA), is an 83 kDa, four domain
protein that binds to the extracellular von Willebrand factor A (vWA) integrin-like I domain
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of either one of two identified host cell receptors, anthrax toxin receptor 1/tumor endothelial
marker 8 (ANTXR1/TEM8) or anthrax toxin receptor 2/capillary morphogenesis protein 2
(ANTXR2/CMG2) (2,3). Binding of PA to the receptor vWA domain is followed by
cleavage of PA into two fragments of 63 kDa and 20 kDa, by a cell-surface furin protease
(4), leading to the spontaneous formation of a ring-shaped heptameric (PA63)7 structure
termed the prepore (5). Formation of the prepore creates binding sites for the enzymatic A
components, edema factor (EF) and lethal factor (LF), which bind with a stoichiometry of
three EF or LF’s per prepore (6). In addition, PA has been shown recently to form functional
octameric (PA63)8 complexes on host cell surfaces (~20–30% of the population of
oligomers), which are capable of binding four EF or LF’s per octamer (7).
Next, the entire complex is endocytosed (8,9) and trafficked to late endosomes which
become acidic (10). At the low pH of the endosome (~5–6), the prepore undergoes a major
conformational change in which β-strands from domain 2 unfold and insert into the
endosomal membrane, forming a transmembrane β-barrel structure called the pore (11–14).
Formation of the pore allows EF or LF, in an unfolded state, to translocate through the pore
into the cell cytosol, a process that is driven by the established pH gradient between the
endosome and cytosol (15,16). Once in the cytosol, EF and LF are able to manifest their
toxic effects - EF is an adenylate cyclase(17) and LF is a zinc-dependent
metalloprotease(18).
Although we have significantly advanced our understanding of PA and the mechanisms
related to translocation (19,20), it is not yet known specifically which amino acid residues
are responsible for triggering pore formation in response to low pH. Originally, histidine
protonation was proposed as a likely mechanism for pore formation, since the pH at which
pore formation occurs in solution (~pH 7) is near the pKa of histidine (~6) (21,22). In
addition, four of the ten histidines in PA (nine in the prepore) reside within a sequence of
domain 2 that comprises the β-barrel portion of the pore (His 299, His 304, His 310 and His
336) (13,14).
In previous work, we have shown that uniform labeling of PA with 2-fluorohistidine (2-
FHis), an isosteric analog of histidine having a reduced side-chain pKa (~1), has differential
effects on the 83 kDa 2-FHisPA and prepore (2-FHisPA63)7 structures (23). While 2-
FHisPA exhibits greater stability to pH (pKapp of 3.6 vs. 5.9 for WT PA), the 2-FHis-
prepore can undergo the conformational change to a pore at pH values similar to the WT
prepore. Because of the reduced pKa of 2-FHis which likely prevents protonation at low pH
(~5), we took this as evidence that histidine protonation is not the trigger for pore formation.
However, aside from the effect on pore formation, we also observed little to no translocation
of the N-terminal domain of lethal factor (LFN) through the pore of the (2-FHisPA63)7, as
measured by ion conductance through planar lipid bilayers. Additionally, 2-FHisPA was
found to be ineffective in mediating cytotoxicity of CHO-K1 cells by LFN-DTA, a fusion
between LFN, the N-terminal prepore binding domain of lethal factor and the catalytic A-
domain of diphtheria toxin.
Here, we further examine the origin of the defect in cytotoxicity. We show that the defect
cannot be explained solely through a defect in translocation, and show that pore formation of
the receptor bound 2-FHis-prepore is blocked. Our combined results lead to a model in
which binding to the cellular receptor enhances hydrogen bonding interactions to the
histidines, which prevents premature protonation and pH unfolding to form a membrane
spanning pore until it reaches the correct cellular compartment.
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Mutagenesis, production and purification
E. coli strain UTH780, a strain auxotrophic for histidine, was used for labeling PA and
mutant proteins with 2-FHis(24). Synthesis of 2-FHis was carried out as described
previously (25). Expression, production and purification of PA, and labeling with 2-FHis,
were carried out as described previously (23). Proteins labeled with 2-FHis were greater
than 95% labeled as determined by mass spectrometry (23). Mutagenesis was carried out
using the QuikChange mutagenesis kit (Stratagene, La Jolla, CA) and the plasmid pQE80-
PA, with oligonucleotide primers obtained from Sigma Genosys. Sequences were verified
by the Protein and Nucleic Acid Chemistry Laboratory at Washington University in St.
Louis (St. Louis, MO). The vWA domain of CMG2, encoding residues 38–218, was
produced as a GST fusion from plasmid pGEX-4T1-CMG238–218, using E. coli strain BL-21
as described previously (26).
Cytotoxicity assay
The ability of WT, 2-FHis labeled and mutant PA proteins to mediate cytotoxicity of CHO-
K1 cells by LFN-DTA was carried out as described previously (23). Briefly, CHO-K1 cells
were incubated in HAM F-12 medium with 100 nM LFN-DTA and various concentrations
either WT or 2-FHisPA for 4 hours at 37°C in 96 well microtitre plates. The medium was
removed, and new Leu-free medium was added which was supplemented with 3H-leucine
(172 Ci/mmol, 5.8 nM final concentration of leucine). After incubating the cells for 1 hour,
the cells were washed with phosphate-buffered saline and the amount of incorporation
of 3H-leucine from the total cells was measured as described (27,28).
Translocation in planar lipid bilayers
Translocation experiments in black lipid membranes were carried out using a planar lipid
workstation (Warner Instruments, Hamden, CT). Lipid membranes were comprised of 3% 1,
2 diphantanoyl-sn-glycerol-3-phosphocholine (DPhPC) in n-decane (Avanti Polar Lipids,
Alabaster, AL). Typically, 0.1 μL of a 3.1 mg/ml solution of (PA63)7 was added to the cis
membrane which was held at pH 5.5. LFN or LFN-DTA (10 nM) was added to the cis
compartment, and the blockage in channel conductance was measured (19). Translocation
was initiated by the addition of KOH to the trans side of the membrane to pH 7.2. Data were
analyzed using Axograph and reported as fraction of LFN or LFN-DTA translocated.
Potassium release assay
Measurement of the kinetics of potassium release from purified 1, 2-dioleoyl-sn-glycerol-3-
phosphocholine (DOPC) vesicles was done as described previously (23,29).
SMRC NMR
SMRC experiments were performed in a manner similar to that described by Rajapaksha
(26). CMG2 was labeled uniformly with 13C using M9 minimal media in which the glucose
was replaced with U-13C-glucose (0.2 %), using BL21-DE3 cells transformed with the
pGEX-4T1 CMG2235–325 gene and purifying as described previously (26).
Deuteration, Digestion and Mass spectrometry of PA and PA-CMG2 complex
PA (1 nmol) and PA-CMG2 complex (1 nmol of PA and 5 nmol of CMG2) were incubated
in 200 μL of 50 mM CHES buffer (pH* 9.5) made with D2O that contains 50 mM NaCl and
1 mM MgCl2 at 37°C for 48 h. The pH* value is the direct pH meter reading of the D2O
buffer solutions uncorrected for the isotope effect at the glass electrode. The final D2O
content in the reaction mixture was 95%. The reaction was stopped by mixing with 5 μL
Wimalasena et al. Page 3













formic acid, and the protein was freed from the buffer salts using an Ultra Micro Spin C4
column (Nest Group, Southboro, MA) according to the manufacturer’s instructions and
dried in a Speed Vac. An aliquot (250 pmol) was dissolved in 50 mM ammonium
bicarbonate and digested either with a combination of trypsin (0.25 μg) and chymotrypsin
(0.25 μg) or with chymotrypsin alone (0.25 μg) at room temperature for 30 min. The
proteases used were immobilized proteases from Princeton Separations (Adelphia, NJ). All
the rapidly exchanging deuterons such as the backbone amide deuterons are back-exchanged
for hydrogens during the digestion.
The digests were analyzed by LC-MS/MS using an UltiMate 3000 LC systems (Dionex, San
Francisco, CA) interfaced to a LTQ-FT mass spectrometer (Thermo-Finnigan, Breman,
Germany). The protein digests (10 pmol) were injected into a reversed-phase C18 PepMap
trapping column (0.3 × 5 mm, 5 μm particle size, Dionex) equilibrated with 0.1% formic
acid/2% acetonitrile (v/v) and washed for 5 min with the equilibration solvent at a flow rate
of 25 μL/min, using an isocratic loading pump operated through an autosampler. After the
washing step, the trapping column was switched in-line with a reversed-phase C18 Acclaim
PepMap 100 column (0.075 × 150 mm, Dionex) and the peptides were chromatographed
using a linear gradient of acetonitrile from 2% to 50% in aqueous 0.1% formic acid over a
period of 60 min at 300 nL/min and the eluate was directly introduced into the mass
spectrometer. The mass spectrometer was operated in a data-dependent MS to MS/MS
switching mode, with the two most intense ions in each MS scan subjected to MS/MS
analysis. The full MS scan was performed at a resolution of 60000 and the subsequent MS/
MS analysis was performed at a resolution of 30000. The total scan cycle frequency was
approximately 1 sec. The precursor ion isolation width was set to be m/z ± 2.0 that allowed
the transmission of the M and M+2 isotopic ions of the peptide for CID. The data was
entirely collected in the profile mode. Xcalibur software (version 2.0.5, build 0704, Thermo-
Finnigan) was used for instrument control, data acquisition, and data processing.
The pseudo-first-order rate constant (kϕ) of H-D exchange reaction was determined by
monitoring the changes in the ratios of M+1/M isotopic peak of a given peptide before and
after the H-D exchange reaction, IM+1(0)/IM(0) and IM+1(t)/IM(t), respectively, using the
following equation.
where, R(0) = IM+1(0)/IM(0) and R(t) = IM+1(t)/IM(t), P is the fractional D2O content in the
solvent (P = 1 when D2O content is 100%) and t is the incubation time (h). The half-lives
(t1/2, day) of the exchange reaction were estimated using the equation: t1/2 (day) = ln2/kϕ/24.
X-ray Crystallography
2-FHisPA concentrated to 16.5 mg/mL in 150mM NaCl, 10mM Tris pH 8.0 was screened
for crystallization in Compact Jr. (Emerald BioSystems) sitting drop vapor diffusion plates.
Crystals were grown using 0.5uL of crystallization solution (30% PEG 400, 100mM Tris pH
8.2) and 0.5uL of protein equilibrated against 100uL of crystallization solution at 20°C.
Elongated prismatic crystals were obtained within 24 hours. Single crystals were transferred
to a fresh drop of crystallization solution and frozen in liquid nitrogen for data collection.
Data were collected at the Advanced Photon Source IMCA-CAT beamline 17BM using an
ADSC Quantum 210r CCD detector. Intensities were integrated and scaled using the
HKL2000 package (30). The coordinates from a previous structure of 2-FHisPA, determined
in-house, were used for initial refinement against the processed diffraction data. Positional
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and isotropic B-factor refinement was conducted with Refmac (31). Anisotropic
displacement parameters were modeled in the final stages of refinement by including 4 TLS
groups as determined from the TLSMD server(32). Manual model building was performed
with Coot (33). Side chain residues that were not masked by electron density were truncated
to the point where electron density was present. Positive difference (Fo-Fc) electron density
consistent with a PEG 400 molecule was observed at a 3σ contour level near Lys 496 and
was subsequently modeled at this site. Structure validation was carried out using Molprobity
(34). The coordinates and structure factors have been deposited to the Protein Data Bank
with the accession code 3MHZ.
Results
Identification of H299 as the cause of the defect in translocation upon labeling with 2-FHis
Toward understanding the observed defect in translocation associated with 2-FHis labeling,
we reasoned that replacing the His residues lining the PA pore channel with 2-FHis might
alter the structure of the lumen of the pore and block translocation, or, alternatively, that
histidine protonation is critical to the mechanism of protein translocation. Biochemical
experiments using cysteine-scanning mutagenesis combined with 2-(trimethylammonium)
ethylmethane-thiosulfonate (MTS-ET) labeling have demonstrated that H304 and H310 are
the only two histidine residues within the lumen of the channel, while H299 and H336 lie on
the exterior facing the lipid bilayer (13,14). In the course of our studies, we constructed a
double mutant of H304/310Q and an H299Q mutant, to probe the role of these histidines in
translocation. These mutants were able to insert into membranes and translocate LFN as
measured by ion conductance across planar lipid bilayers, with kinetics similar to WT PA
(Figure 1A). These mutants were then uniformly labeled with 2-FHis and purified, and the
translocation experiments repeated. While translocation was blocked for the 2-FHisPA and
the 2-FH304/310Q mutant, the 2-FH299Q mutant was able to translocate LFN (Figure 1A),
suggesting that fluorination of H299 causes the defect in LFN translocation.
H299Q PA labeled with 2-FHis does not restore the defect in cytotoxicity
Despite the ability to translocate LFN, the 2-FH299Q mutant was unable to restore the defect
in cytotoxicity (Figure 1B). Along with the unlabeled WT, H299Q and H304/310Q mutants,
which are functional and cytotoxic, we have included the corresponding WT and mutants
labeled with 2-FHis. The 2-FHis-labeled proteins were all non-cytotoxic. Since the planar
bilayer experiments utilize LFN, whereas the CHO-K1 cell experiments utilize LFN-DTA,
we hypothesized that perhaps the inability of the 2-FH299Q mutant to mediate cytotoxicity
was related to an inability to translocate LFN-DTA, which is a significantly longer substrate
than LFN, and may therefore be more energetically difficult to unfold and move through the
membrane. Experiments in which LFN-DTA was used in the translocation assay indicated
that both the H299Q and the 2-FH299Q labeled proteins were able to translocate LFN-DTA
(Supplementary Figure S1, Supporting Information), suggesting that other mechanisms may
be responsible for the defect in cytotoxicity, and must not be limited to translocation.
Effect of 2-FHis labeling on pore formation in the presence of the receptor
In our previous study we showed that both WT and 2-FHisPA proteins were able to bind to
the cell surface, indicating that interactions with the host cellular receptor were unperturbed
(23). However, it was possible that effects on steps subsequent to receptor binding, along the
pathway leading up to translocation, may contribute to the observed defect in cytotoxicity.
Receptor binding decreases the pH required to initiate pore formation by ~1–2 pH units,
from a pH of ~7 to ~5–6 (35–37). We therefore purified the receptor binding vWA domain
of CMG2, to study the effect of the receptor on low pH-induced pore formation.
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PA has been shown to bind the vWA domain of CMG2 with high affinity (~200 pM) (38).
Both PA and 2-FHisPA could form a stable complex with the vWA domain of CMG2 as
determined by a gel shift assay (Figure 2A) (26). In our previous study we showed that both
the WT and 2-FHis prepore proteins exhibited similar pH-dependent properties in terms of
pore formation, as determined by SDS-PAGE as well as by monitoring kinetics of potassium
release from purified liposomes (23). In the current study, we also monitored pore formation
using similar assays, but in the presence of the vWA domain. Using the SDS-PAGE assay,
while pore formation of WT (PA63)7 could be observed at pH 6, pores of (2-FHisPA63)7
were only faintly observed at pH 6 and 5, suggesting that pore formation of (2-FHisPA63)7,
in the presence of the vWA domain, is largely blocked (Figure 2B). Likewise, potassium
release experiments showed that while the WT (PA63)7 exhibits the expected increase in
potassium release in the presence of the vWA domain (29), potassium release of (2-
FHisPA63)7 was ~10% of that of the WT-vWA domain complex (Figure 2C). This indicates
that the vWA domain of the receptor, when bound to (2-FHisPA63)7, causes a change in the
(2-FHisPA63)7 prepore state such that it is largely incapable of forming a pore.
Block in receptor dissociation from the 2-FHis labeled prepore at low pH
Rainey and co-workers have demonstrated that receptor dissociation occurs at pH values
commensurate with pore formation, and thus it was possible that the block in pore formation
may be a consequence of an inability of the receptor to dissociate from the (2-FHisPA63)7
prepore. To provide evidence of receptor dissociation from the (2-FHisPA63)7 prepore, we
followed the pH dependence of the 1-D 1H-13C-HSQC NMR spectrum of a uniformly 13C-
labeled vWA domain of CMG2 in the presence of either (2-FHisPA63)7 or WT (PA63)7, by
focusing on the strongest methyl resonance of carbon-13 (SMRC) (Figure 3) (26,39). In this
assay, we used an approximate 2-fold higher concentration of 13C-CMG2 in order to
observe residual 1H resonance intensity, since a 1:1 stoichiometry results in extreme line
broadening and a complete loss in resonance intensity. The results at pH 8.1 show that both
the WT and 2-FHis-labeled prepore proteins are able to associate with 13C-CMG2, as shown
by a significant decrease in resonance intensity (compare intensity with no prepore added
(spectrum A) to that with prepore proteins added (B and C)). At a reduced pH of 5.7, where
pore formation is known to occur, resonance intensity of 13C-CMG2 bound to the WT
(PA63)7 prepore increased, indicative of receptor release, while the intensity of 13C-CMG2
bound to (2-FHisPA63)7 was unchanged, indicating that 13C-CMG2 remained bound. This
further supports the SDS-PAGE and potassium release experiments showing that pore
formation is largely blocked in the presence of the receptor, and suggests that the defect in
cytotoxicity associated with 2-FHis labeling is a combination of both a defect in
translocation (due to a 2-FH299) and a defect in pore formation, but only when bound to the
receptor.
Crystal Structure of 2-FHisPA
These results suggested that the combination of 2-FHis labeling and receptor binding
increased the pH stability of the prepore such that low pH-induced pore formation is
blocked. Since pore formation of 2-FHis and WT prepore proteins, in the absence of the
receptor, could occur at identical pH values (23), we reasoned that receptor binding must
somehow alter the local environment around the 2-FHis side-chains in such a way as to
stabilize the structure against changes in pH. Critical to our understanding then was to
determine if the local environment (i.e., van der Waals contacts, hydrogen bonding) around
the histidine side-chains is affected by the presence of fluorine, and whether receptor
binding changes the environment around the histidine side-chains in such a way as to
prevent protonation.
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Toward understanding whether the environment around the histidine side-chains are affected
by labeling with fluorine, we have determined, to 1.7 Å resolution, the crystal structure of
the full-length, 83 kDa form of 2-FHisPA (Figure 4B). The structure overlays quite well
with WT PA (RMSD = 1.118 Å) (40), as well as the WT PA-CMG2 complex (RMSD =
0.933 Å) (22). The refinement statistics are shown in Table 1. With the exception of 2-
FHis-211, 304 and 310 (which are not observed in the crystal structure), all of the 2-FHis
residues adopt similar side-chain conformations compared to the WT PA and PA-CMG2
structures (Figure 4C), indicating that the presence of fluorine does not significantly perturb
the local environment. The histidine side-chains are also involved in similar hydrogen
bonding interactions, and because we can visualize the fluorine atom at the 2-position, the
N-π and N-τ atoms of the ring can be differentiated (Figure 4A).
Hydrogen bonding to the side-chains of 2-FHis
To assess hydrogen bonding to a 2-FHis or His residue, we measured the distances, along
with two other parameters - the tilt angle and the planar angle (Figure 5), from either the N-π
or N-τ of the imidazole ring to polar atoms ~ 3 Å away. The tilt angle is similar to the angle
between the Fe2+ to His F8 in hemoglobin used to distinguish the T to R transition (41). The
planar angle is the angle measured either above or below the plane of the ring, relative to the
center of the ring. A summary of the tilt and planar angles to polar atoms from 2-FHis
residues are shown in Table 2, along with measurements taken from the WT PA and PA-
CMG2 structures.
It is important to note that the pH values and resolution of the three structures are different
(pH 8.2 and 1.7 Å for 2-FHisPA, pH 6 and 2.1 Å for WT PA, and pH ~9 and 2.5 Å for WT
PA-CMG2 complex), and structural changes occur as the pH is lowered - the domain 2 loop
connecting strands β3-β4 in WT PA is disordered at low pH(40). The values in Table 2
suggest that for most of the 2-FHis residues, the hydrogen bonds to the N-π and N-τ atoms
are similar to that in either the WT PA or PA-CMG2 protein structure. An exception is 2-
FH597, which forms a polar interaction with the Oδ1 of D608 in the WT PA and PA-CMG2
complex, but in the 2-FHisPA structure the D608 side-chain is rotated away from 2-FH597
(Figure 4D). In 2-FHisPA, this interaction is replaced with a water molecule. Hydrogen
bonding for all observed 2-FHis residues is depicted in Figure 6.
We also note that in the crystal structure of 2-FHisPA, we are able to observe the loop
connecting strands β1 and β2 (residues D276-R287) and the loop and small helix connecting
strands β3 and β4 (residues S339-T357) (Figures 4C). The latter region could be observed in
crystal form 1 of WT PA (obtained at pH 7.5) (40), however this structure was never
deposited in the PDB and thus a comparison to our structure was not possible. In that
structure, the loop connecting strands β1 and β2 was not observed. We have included the
electron density surrounding these loop regions in the Supporting Information
(Supplementary Figure S2). The presence of a crystal contact between R344 and a symmetry
related E224 side-chain from another 2-FHisPA molecule likely contributes to the
stabilization and observation of the β3-β4 loop (Supplementary Figure S3 – Supporting
Information).
Other noncovalent contacts to 2-FHis side-chains
The electronic properties of the C-F bond are quite different from the C-H bond, and the
bond length is slightly longer (1.47 Å versus 1.09 Å, respectively). These properties may in
some cases strengthen (or weaken) other types of noncovalent interactions with nearby
atoms –examples include an effect on molecular packing and van der Waals
interactions(43), hydrophobicity(44,45), or dipole interactions(46,47). For instance, the C-F
bond of 2-FH253 is in a hydrophobic patch that is surrounded by Y219, L255 and I529.
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Similarly, the C-F bond of 2-FH616 is pointing towards a hydrophobic pocket containing
V612, I635 and L639. In terms of potential dipole interactions, the C-F bond of 2-FH299 is
pointing towards R490, which is within range to form either a C-F---H-N hydrogen bond to
the NH2 of the guanidinium (Gdn), or may be involved in a charge-dipole interaction (Cδ+-
Fδ----Gdn+). These interactions are represented in Figure 7. Since the side-chains of the
amino acids surrounding the C-F bonds (hydrophobic or otherwise) have not assumed
alternative geometries, this indicates that the C-H to C-F substitutions in PA are isosteric
and will likely not affect local structure.
Effect of receptor binding on the rate of H-D exchange to histidine side-chains in PA
Toward understanding whether receptor binding changes the local environment around the
histidine side-chains, we have monitored the exchange rate of the C2 imidazole hydrogen of
all histidine side-chains in WT PA for deuterium by mass spectrometry (48,49). In this
study, both PA alone and the complex with CMG2 were subjected to H-D exchange at
pH*9.5, followed by protease digestion to afford peptides which contained each of the
histidines. The resulting peptides were analyzed by LC-MS/MS. All ten histidine residues
were detected in eight different peptides (Table 3). Initially, the peptides were assigned to
the amino acid sequence of PA by matching the experimentally obtained peptide masses to
their expected molecular masses. The tandem mass spectra for these peptides ensured that
the assignments were correct (Supplementary Figure S4a-h, Supporting Information).
Peptide ions used for calculating the rate constants (kϕ) of H-D exchange at each of the
histidine residue are also shown in Table 3. The t1/2 values of H-D exchange at each of the
histidines, both in the presence and absence of CMG2, are shown in Table 4.
First, the data show that the t1/2 values are consistent with the degree of solvent exposure of
each of the side chains seen in the crystal structure. For instance, both H83 and H597, which
have short t1/2 values (less than 1 day), are solvent exposed; H253 and H616 have very long
half lives – H253 is in a region which has low temperature factors, and H616 is buried
within the core of domain 4 (see Figure 7). In the presence of the receptor, the most dramatic
changes in the t1/2 values are centered within domain 2, and include H299, H336 (exchange
rates ~3-fold slower) and H304 (~2-fold slower rate). This indicates that receptor binding
either stabilizes hydrogen bonding interactions to these histidine residues, or decreases the
ability of these histidines to exchange protons with solvent. With the exception of H336,
which lies at the interface between domain 2 and domain 4 (Figure 4), and H304 (which is
not observed in the crystal structure), H299 is >40 Å from the binding interface.
Discussion
The role of histidine in governing the conformational change from a soluble prepore to a
membrane spanning pore was first investigated in a previous study by labeling PA with 2-
FHis, an isosteric analog of histidine with a side-chain pKa of ~1 (23). In that study, we
showed that 2-FHisPA is defective in mediating cytotoxicity of CHO-K1 cells by LFN-
DTA, and here we demonstrate that this defect is likely due to a combination of two separate
processes - an inability to translocate derivatives of LF, and an inability to form a
membrane-spanning pore when bound to the vWA domain of CMG2.
The defect in translocation associated with 2-FHis labeling is shown to be due primarily to
2-FH299, which, based on previous biochemical experiments, is projected to be on the
outside of the pore in contact with the solvent (13,14). It may be that labeling H299 with 2-
FHis causes a deformation of the pore structure that prevents translocation, an effect that
does not occur upon mutation of H299 to glutamine. In any case, the ability of the 2-
FH299Q mutant to translocate LFN suggests that histidine protonation is not directly
involved in the process of protein translocation.
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Despite the ability to translocate LFN, the 2-FH299Q mutant was incapable of mediating
LFN-DTA cytotoxicity of CHO-K1 cells. Using a combination of SDS-PAGE, potassium
release experiments and HSQC-NMR, we show that pore formation of the 2-FHis labeled
(PA63)7 is, to a large extent, blocked in the presence of the vWA domain of CMG2. We use
the term “large extent” to note that the block we observe in the SDS-PAGE assay and
potassium release assay is not complete – as mentioned, we are able to observe faint bands
at pH 5 and 6 in the SDS-PAGE assay, and a small increase in potassium release. This may
indicate that there is a small amount of unlabeled, WT PA in our preparation, or that the
mechanism of pore formation is heterogenous. In the latter case, there may be some fraction
of 2-FHis-labeled molecules that, upon binding to the receptor, is in a conformation where
pore formation occurs at pH values similar to the WT protein. However, for the majority of
molecules we observe, the combination of 2-FHis labeling and receptor binding is sufficient
to block low pH induced pore formation.
Pore formation is known to involve the peeling of domain 2 strands β2 and β3 from domain
2, since residues from these two strands largely comprise the 70 Å long pore (13,14).
However, the crystal structure of WT PA or prepore bound to CMG2 (22,35) revealed that,
while the receptor binds primarily to domain 4, the receptor also interacts with a loop
connecting the domain 2 strands β3 and β4 (Figure 4C). This loop was hypothesized to be
important for enhancing the stability of the prepore to pH (22). For instance, the pH
threshold for pore formation is reduced from a pH of ~7 in the absence of the receptor to ~6
when bound to TEM8 and ~5 when bound to CMG2 (36,37). Residues in CMG2 which
form hydrogen bonds with the domain 2 β3-β4 loop have been shown to be important for the
enhanced pH stability of the prepore (36,50,51). Mechanistically, binding of the receptor
stabilizes the domain 2 β3-β4 loop, which stabilizes domain 2 against pH-dependent
changes.
The addition of the receptor to WT PA also reduces the rate of H-D exchange of the C2
imidazole hydrogen of histidine residues 304, 299 and 336 within domain 2 (Table 4).
Therefore, the stabilizing influence of receptor binding is not only localized to the domain 2
β3-β4 loop, but is propagated to sites distant from the binding interface. Based on the crystal
structures of PA and PA bound to CMG2, the environments around the histidine side-chains
are virtually identical, suggesting that the slower rate of H-D exchange is unlikely to be due
to a decrease in solvent exposure. Unfortunately, we could not confirm that the pKa of the
histidine side-chains decrease upon binding the receptor, which may occur if the hydrogen
bonds to the histidine imidazole (acting as a proton acceptor) are strengthened. Further, we
could not confirm that the rate of H-D exchange is also slowed upon binding the receptor to
2-FHisPA using the C2 exchange strategy. H-D exchange at the C2 of histidine proceeds
through the abstraction of the C2 proton from the cationic imidazolium (both nitrogens
protonated) by OD-, to form an ylide or a carbene intermediate, which is the rate-
determining step in the reaction (48). An analogous exchange with 2-FHis cannot be
observed because this would require formal removal of F+, an energetically impossible
event.
The stability to pH of 2-FHisPA is greater than WT PA (pKapp of 3.6 vs. 5.9 for WT PA)
(23). Despite the observed increase in pH stability, the prepore form undergoes pore
formation at nearly identical pH values as the WT (23). This would indicate that the pH
stabilizing influence of 2-FHis is lost upon conversion to the prepore. But, in the presence of
the receptor, pH-dependent pore formation from the (2-FHisPA63)7 prepore is, to a large
extent, blocked. This would indicate that receptor binding restores the pH stability observed
in the full-length, monomeric 2-FHisPA. The H-D exchange experiments also indicate that
histidine protonation, required for the process of H-D exchange in our strategy, is slowed for
WT PA in the presence of the receptor. Together with the crystal structure of 2-FHisPA and
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the comparison of hydrogen bonding patterns to the WT and PA-CMG2 structures, our
combined results indicate that receptor binding prevents protonation of histidine residues,
which subsequently blocks low-pH induced pore formation.
To explain how receptor binding may influence protonation, we propose a model in which
the prepore structure is rather dynamic and “floppy” - binding of the receptor to the prepore
decreases this motion, resulting in the strengthening of hydrogen bonding interactions and
an overall tightening of the structure. The model of positive cooperativity put forth by
Williams would indicate that binding of the receptor results in an overall tightening of the
structure which experiences, in the absence of receptor, extensive molecular motion (52,53).
In a similar system, calorimetric analysis of the binding of the receptor ganglioside GM1 to
diphtheria toxin was shown to exhibit positive cooperativity (54). Evidence from
experiments monitoring pore formation as a function of pH have already shown that receptor
binding to the WT PA prepore leads to an increase in the degree of cooperative interactions
– while the pH stability is enhanced, the slope of the transition from a prepore to a pore is
much steeper and occurs over a narrower pH range (35,37). Binding of the receptor may
decrease the global molecular motion of the prepore, facilitating an increase in hydrogen
bonding interactions, and thereby eliciting a similar positive cooperative effect.
Since all of the 2-FHis residues will have a lower pKa compared to their histidine
counterparts, those histidines in which protonation disrupts hydrogen bonding will likely
remain unprotonated at pH 5, such that the hydrogen bonds to the 2-FHis imidazole ring
(which may be strengthened by receptor binding) are maintained. Due to the electron
withdrawing inductive effect of the fluorine, the 2-FHis imidazole nitrogens are expected to
be relatively weak hydrogen bond acceptors, due to the less basicity of the imidazole
nitrogens, but better hydrogen bond donors. Since we cannot assign to which nitrogen the
hydrogen is located, it is difficult to determine which of the two nitrogens is participating as
a hydrogen bond donor or acceptor. We can surmise, for instance, that the NH of L255 is
participating as a hydrogen bond donor to the π nitrogen of H253; similarly, the NH of G253
likely donates a hydrogen bond to the π nitrogen of H299 (Table 1). Protonation of the π
nitrogen at these, or other sites, would be expected to disrupt hydrogen bonding. However,
labeling with 2-FHis may prevent protonation, such that these hydrogen bonds are
maintained.
Although all of the 2-FHis residues that we could observe are involved in hydrogen bonding
interactions, we cannot rule out that other types of noncovalent interactions are also
influenced by 2-FHis labeling, including electrostatic/dipole or hydrophobic interactions
(Figure 7) (43–47). Since the side-chains of the amino acids surrounding the C-F bonds have
not assumed alternative geometries or packing from that of the WT protein, this suggests
that the C-F bond may exhibit only minor changes in local interaction energies. Nonetheless,
a “polar-hydrophobic” effect might increase stability without leading to altered geometries.
Thus, as discussed by DiMagno and coworkers, the C-F bond is polarized, and in an
aqueous environment, water molecules are aligned with the C-F dipole. When the C-F bond
enters a hydrophobic pocket, these water molecules are shed leading to an increase in
entropy and an increase in stability (47).
Given that we know so little about the effect of fluorine on the electronic properties of 2-
FHis, but do know that 2-FHis has a lower pKa and thus is more difficult to protonate at
physiologic pH, our combined results are most consistent with an effect on protonation. This
conclusion is also consistent with studies in which RNaseA was chemically synthesized to
contain 4-fluorohistidine (4-FHis), another analog of histidine with a side-chain pKa of 3.5.
The pH-rate profiles observed were consistent with a lower pKa of 4-FHis, lowering the pH
required for catalysis, without an effect on enzyme structure (55).
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In conclusion, our study suggests that protonation of histidine residues, in particular those in
domain 2, contributes to the mechanism of pore formation, but only when bound to the
receptor. Further, our study suggests that there are at least two separate mechanisms for pore
formation – one in which the receptor is unbound and histidine protonation is unimportant,
and another in which the receptor is bound and histidine protonation becomes a part of the
mechanism for pore formation. Understanding how these mechanisms may cooperate in
controlling pH-dependent pore formation will certainly contribute to a better understanding
of anthrax disease pathogenesis.
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Abbreviation
ANTXR1 anthrax toxin receptor 1
ANTXR2 anthrax toxin receptor 2
C-F carbon-fluorine bond
CHO-K1 chinese hamster ovary K1 cells
CMG2 capillary morphogenesis protein 2
EF edema factor
2-FHis 2-fluorohistidine
2-FHisPA the 83 kDa form of 2-FHis labeled PA
(2-FHisPA63)7 the 63 kDa, heptameric form of 2-FHis labeled PA
H-D hydrogen-deuterium
Gdn guanidinium
HSQC heteronuclear single quantum coherence
LC liquid chromatography
LF lethal factor
LFN N-terminal PA binding domain of LF




Wimalasena et al. Page 11














SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SMRC strongest methyl resonance carbon-13
TEM8 tumor endothelial marker 8
vWA von Willebrand factor A domain
WT wild-type
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(A) Translocation of LFN shown as a function of time during macroscopic conductance
measurements taken using a planar phospholipid bilayer system. Representative planar lipid
bilayer macroscopic conductance records (from experiments of n≥3) are shown for labeled
(open symbols - □, 2-FWT; ○, 2-FH299Q;△, 2-FH304/310Q) and unlabeled (closed
symbols - ■, WT; ●, H299Q; ▲, H304/310Q) WT PA and histidine mutant PA proteins as
indicated. Records are normalized as fraction translocated. (B) Cytotoxicity as determined
by protein synthesis inhibition mediated by PA proteins translocating LFN-DTA into the
cytosol of CHO-K1 cells. Plotted are the mean of ≥ 3 experiments plus the standard
deviation. Cytotoxicity of unlabeled WT and histidine mutant PA proteins (closed symbols -
■, WT; ●, H299Q; ▲, H304/310Q) and 2-FHis-labeled WT and histidine mutant PA
proteins (open symbols - □, 2-FWT; ○, 2-FH299Q; △, 2-FH304/310Q) are shown.
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(A) Binding of CMG2 to WT PA (left lanes) and 2-FHisPA (right lanes). Each lane contains
5 μM PA; the numbers above each lane correspond to the stoichiometry of CMG2 to PA.
Samples were loaded onto a native 4–20% PAGE gel and run for ~3 h at constant voltage
(40 mV). (B) Conversion of (PA63)7 and (2-FHisPA63)7 from a prepore (pH 8.5) to a pore
state in the presence of CMG2. Each lane contains ~0.9 μM PA63 and 5 μM CMG2. Buffers
(350 mM final) used were BisTris (pH 5 and 6) and HEPES (pH 7 and 8). (C) Potassium
release from purified liposomes. Liposomes contained 150 mM KCl, 10 mM HEPES (pH
7.4) and were bathed in 50 mM sodium acetate, 150 mM NaCl, (pH 5.0). PA prepore (3
nM), either alone (■, WT; ●, 2-FHisPA) or complexed with CMG2 (40 nM) (□, WT; ○, 2-
FHisPA) was added to the liposome solution and K+ release was monitored with a K+-
selective electrode (Orion Research) continuously. Buffer control is shown (△). The traces
shown are representative of three experiments.
Wimalasena et al. Page 16














1H-13C-HSQC to determine the influence of pH on release of 13C-CMG2 from the prepore
of (PA63)7 and (2-FHisPA63)7. All experiments were performed at 25°C. Either PA63 (31
μM) or 2-FHisPA63 (39 μM) in 0.5M NaCl, 20 mM Tris-d11, pH 8.5 was added to 13C-
labeled CMG2 (20 μL) in 0.1M NaCl, 10 mM HEPES-d18, pH 7.4 in a volume of 100 μl to
give a final concentration of 15 μM PA63 and 2-FHisPA63 and 30 μM CMG2. The binding
reaction was incubated for ~1 h at room temperature, to which 400 μL of a universal pH
buffer (56 mM each of cacodylic acid-d7, Bis-Tris-d19, and Tris-d11, 1.0% β-D-octyl-
glucoside-d24, and 12.5% D2O) at pH 8, 6 or 5 was added. The final pH for A, B and C was
8.1 ± 0.1; for D, E and F it was 6.3 ± 0.1; and for G, H and I it was 5.7 (± 0.1). Final
concentration of 13C-CMG2 for each spectrum is 6 μM. Spectra A, D and G correspond to
free 13C-CMG2 (unbound) and show virtually superimposable profiles. The final
concentration of WT PA63 (B, E and H) and 2FHisPA63 (C, F and I) is 3 μM. Note the
difference in intensity of 13C-CMG2 at pH 5.7 for WT PA63 (spectrum H) and 2FHisPA63
(spectrum I). Each spectrum represents 2048 transients acquired on an 800 MHz NMR
(Bruker – University of Kansas) equipped with a cryoprobe (acquisition time was 1 h for
each experiment).
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(A) 2Fo-Fc electron density map of 2-FHis299 contoured at 1σ.
(B) Crystal structure of 2-FHisPA (PDB:3MHZ). Domain 1: S15-A258 (magenta), Domain
2: Y259-T487 (blue), Domain 3: T488-R595 (coral), Domain 4: F596-I734 (green). 2-FHis
residues are represented as red sticks. (C) Superposition of 2-FHisPA (magenta) and WT PA
(cyan)-CMG2 (green) complex (22). The 2-FHis and histidine residues are colored red and
grey, respectively. (D) Superposition of H597 and D608 in WT PA (light green), PA-CMG2
complex (cyan) and 2-FHis597 and D608 in 2-FHisPA (magenta).
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Depictions of the tilt and planar angles. The imidazole ring of 2-FHis299 in this example is
colored magenta and a water molecule is represented as a red sphere. (A) The tilt angle is
defined as the angular deviation of a particular atom from the plane (bold line) that bisects
an N-π or N-τ atom and its opposing N-C bond of the imidazole ring. (B) The planar angle is
defined as the angular deviation of a particular atom from the mean plane defined by the
imidazole ring atoms (bold line). The distance from the N-π or N-τ to the atom in question is
defined as D and its distance from the mean plane as r. The magnitudes of D and r are
measurable quantities and the planar angle can then be calculated by: planar angle = sin−1 (r/
D).
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Hydrogen bonding of 2-FHis residues in the crystal structure of 2-FHisPA showing residues
in individual domains. (A) Domain 1, residues S15-A258, (B) 2-FHis253 from Domain 1
and Domain 2, residues Y259-T487 and (C) Domain 4, residues F596-I734. Water
molecules are drawn as red spheres.
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Superposition of residues in WT PA-CMG2 complex (light green) and 2-FHisPA (magenta)
near the C-F bond of certain 2-FHis residues. ( A) 2-FHis253, (B) 2-FHis299 and (C) 2-
FHis616.
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Table 1
Data collection and refinement statistics for 2-FHisPA.
2-FHisPA
Data Collection
 Unit-cell parameters (Å,°) a = 71.37, b = 93.98, c = 119.12
 Space group P212121
 Resolution (Å) 50.0-1.70 (1.76-1.70)
 Wavelength (Å) 1.0000
 Temperature (K) 100
 Observed reflections 584,535
 Unique reflections 88,352
 <Iσ(I)>1 33.3 (1.9)
 Completeness (%)1 98.7 (89.5)
 Redundancy1 6.6 (4.7)
 Rsym (%)1, 2 9.3 (58.9)
Refinement
 Resolution (Å) 50.0-1.7
 Reflections (working/test) 83,119/4,400
 Rfactor/Rfree (%)3 19.2/22.2
 No. of atoms (protein/Ca2+/PEG 400/water) 5307/2/13/400
Model Quality
 R.m.s deviations
 Bond lengths (Å) 0.016
 Bond angles (°) 1.733
Average B factor (Å2)
 All Atoms 35.6
 Protein 35.4
 Ca2+ 23.6
 PEG 400 56.9
 Water 37.2
 Coordinate error based on Rfree (Å) 0.109
Ramachandran Plot (chain A/B)
 Favored (%) 98.3
 Allowed (%) 1.7
1
Values in parenthesis are for the 1.76 to 1.70 Å resolution shell.
2
Rsym = ΣhklΣi|Ii(hkl) − <I(hkl)>|/ΣhklΣi Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection and <I(hkl)> is the average intensity
of all reflections with indices hkl.
3
Rfactor = Σhkl||Fobs (hkl) | − |Fcalc (hkl) ||/Σhkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% of randomly selected
reflections that were not included in the refinement.
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Table 3
Histidine containing peptides/peptide fragments monitored to obtain rate constants (kϕ) of H-D exchange
peptide1





Ions used for calculating the rate of H-D
exchange, m/z
H86 ATSADNHVTMW A90 - W100 m/z 616.77 and 617.27 (z = 2)
H211 ISNIHEKKGLTKY I217 - Y229 m/z 383.47 and 383.72 (z = 4)
H253 EKVTGRIDKNVSPEARHPL E247 - L265 m/z 430.04 and 430.24 (z = 5)
H263 HVDMENIILS H273 - S282 m/z 585.80 and 586.30 (z = 2)
2 H299/304/310 (H299) THTSE (b5) T308 - E312 m/z 556.23 and 557.23 (z = 1)
H299/304/310 (H314) TSEVHGNAEVHA (y122+) T310 - A321 m/z 625.79 and 626.29 (z = 2)
H299/304/310 (H320) GNAEVHAS (y7) G315 - A321 m/z 697.33 and 698.33 (z = 1)
H336 SNSNSSTVAIDHSL S335 - L348 m/z 716.34 and 716.84 (z = 2)
H597 HYDRNNIAVGADESVVK H607 - K623 m/z 629.65 and 629.98 (z = 3)
H616 NNIAVGADESVVKEAHR N611 - R627 m/z 603.65 and 603.98 (z = 3)
1
H211 and H253 peptides were produced by digesting PA with chymotrypsin. The other peptides were produced by digesting the protein using a
combination of trypsin and chymotrypsin.
2
H299/304/310-peptide (T308-A321) contains H299, H304 and H310. The amino acid sequences, positions and monitored ions shown for H299,
H304 and H310 are for the fragment ions (b5, y122+ and y7, respectively) produced from the precursor peptide (THTSEVHGNAEVHAS) by
collision-induced dissociation.
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Table 4




H86 0.80 ± 0.01 0.88 ± 0.05
H211 11.34 ± 0.79 11.45 ± 0.80
H253 >50 >50
H263 1.75 ± 0.08 1.84 ± 0.10
H299 4.41 ± 0.70 12.16 ± 0.46
H3042 2.17 ± 0.50 4.78 ± 0.58
H310 1.68 ± 0.36 1.83 ± 0.01
H336 8.41 ± 1.50 31.72 ± 5.57
H597 0.66 ± 0.01 0.69 ± 0.02
H616 >50 >50
1
Data are means ± standard deviation from triplicate reactions. See Table 3 for the amino acid sequences of peptides/peptide fragments used to
determine the kϕ.
2
The t1/2 values were determined indirectly by subtracting the rate constant (kϕ) of H-D exchange for His310 from the combined kϕ for His304
and 310.
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